Clinical Trial Update: Oral Piroxicam Versus Buccal Fentanyl in Breakthrough Pain [NA]

View source ↗

Summary

A completed clinical trial compared oral piroxicam with buccal fentanyl for breakthrough pain management in metastatic cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Fentanyl (buccal formulation) (Fentanyl)
• Piroxicam (piroxicam)

Snippet

Sponsor: Tanta University | Conditions: Neoplasm Metastases | NA | Status: COMPLETED